Preferred Name | Stavudine | |
Synonyms |
|
|
Definitions |
A nucleoside reverse transcriptase inhibitor analog of thymidine. Stavudine has been recommended to undergo phase-out management due to its long-term, irreversible side-effects. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C1428 |
|
ALT_DEFINITION |
A drug that belongs to the family of drugs called nucleoside analogues. It is used to treat infection caused by viruses. |
|
CAS_Registry |
3056-17-5 |
|
CHEBI_ID |
CHEBI:63581 |
|
Chemical_Formula |
C10H12N2O4 |
|
code |
C1428 |
|
Contributing_Source |
FDA |
|
definition |
A nucleoside reverse transcriptase inhibitor analog of thymidine. Stavudine has been recommended to undergo phase-out management due to its long-term, irreversible side-effects. |
|
FDA_UNII_Code |
BO9LE4QFZF |
|
in_subset | ||
label |
Stavudine |
|
Legacy Concept Name |
Stavudine |
|
NCI_Drug_Dictionary_ID |
41064 |
|
NSC Number |
163661 |
|
PDQ_Closed_Trial_Search_ID |
41064 |
|
PDQ_Open_Trial_Search_ID |
41064 |
|
Preferred_Name |
Stavudine |
|
prefixIRI |
NCIT:C1428 |
|
prefLabel |
Stavudine |
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
|
UMLS_CUI |
C0164662 |
|
subClassOf |
Create mapping